AMPH logo

AMPH Amphastar Pharmaceuticals, Inc.

NASDAQ Global Select · Drug Manufacturers - Specialty & Generic · Healthcare

$20.91
+0.73 (+3.62%)

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United S…

Market Cap: $921.98Mwww.amphastar.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

100
100
Aug 14Aug 14

Quote

Day Range
$20.00 – $21.07
52-Week Range
$16.65 – $31.26
Volume
$299.9K
Market Cap
$921.98M
50-Day Avg
$19.83
200-Day Avg
$22.77
Prev Close
$20.18
Open
$20.05

Valuation & Ratios

P/E Ratio
12.75
EPS
$2.10
P/B Ratio
1.59
P/S Ratio
1.74
Debt/Equity
0.83
Current Ratio
4.02
Dividend Yield
+0.0%
Gross Margin
+49.5%

Returns & Efficiency

Return on Equity
Return on Assets
FCF Yield
EV/EBITDA

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$719.89M$98.09M$2.10
2024$731.97M$159.52M$3.29
2023$644.39M$137.54M$2.85
2022$498.99M$91.39M$1.88
2021$437.77M$62.12M$1.30

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $0.85 per share

4of 7 quarters beat consensus

Typical surprise +12.1% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$0.91 vs $0.62beat
  • Thu, May 7$0.42 vs $0.70miss
  • Thu, Feb 26$0.73 vs $0.90miss
  • Thu, Nov 6$0.93 vs $0.77beat
  • Thu, Aug 7$0.85 vs $0.71beat
  • Wed, May 7$0.74 vs $0.66beat

Estimates and results for AMPH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from AMPH's reported EPS growth of 12.7% a year over 4 years.

EPS in 5 years
$3.82
Implied price
$49.60
Return from $20.91
18.9% a year

To earn 15.0% a year on these assumptions you'd need to buy at $24.66 — today's price is already 15.2% below that.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E911131517
2.7%0.6%4.8%8.3%11.5%14.3%
7.7%5.5%9.9%13.6%16.9%19.8%
12.7%10.4%15.0%18.9%22.3%25.4%
17.7%15.3%20.1%24.1%27.7%31.0%
22.7%20.2%25.2%29.4%33.2%36.5%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • Newszacks.com·1d ago·Neutral

    New Strong Sell Stocks for August 14th AMPH, CHT and HE have been added to the Zacks Rank #5 (Strong Sell) List on August 14, 2026.

    View source ↗